GeoVax appeals Nasdaq delisting notice tied to minimum bid price rule

• GeoVax faces a Nasdaq delisting determination tied to the minimum bid price rule under Listing Rule 5550(a)(2).
• A hearing before the Nasdaq Hearings Panel is scheduled for Oct. 13, 2026, following an appeal request.
• The appeal stays any suspension or delisting action; shares are expected to keep trading on Nasdaq at least through that period.
• GeoVax plans to present a compliance plan aimed at regaining and maintaining listing standards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeoVax Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-030085), on September 10, 2026, and is solely responsible for the information contained therein.